There is 1 paper on CSFaSynSAA+/DAT+ biomarker profile in aging research: 1 observational study in people.
1 paper studies it1 finding
“The expected biomarker profile (CSFaSynSAA+/DAT+) for clinically-diagnosed synucleinopathy occurred in 74 (71.8%) participants.”
- Humans1
Associations
1Clinical phenoconversion
mixedin humans1
1 study
Clinical phenoconversion
mixedin humans1
Clinical phenoconversion is associated with CSFaSynSAA+/DAT+ biomarker profile in humans (Clinically diagnosed phenoconverters) (74 participants (71.8%) had the expected biomarker profile).
“The expected biomarker profile (CSFaSynSAA+/DAT+) for clinically-diagnosed synucleinopathy occurred in 74 (71.8%) participants.”
HumansClinically diagnosed phenoconvertersn = 103
Synuclein and dopamine transporter biomarkers among phenoconverters to parkinsonian disorders
medRxivPreprint
Latest
1 paper in 12 monthsmedRxiv
Synuclein and dopamine transporter biomarkers among phenoconverters to parkinsonian disorders
Preprint: cohort study of 103 peopleParkinson's disease